IQV - IQVIA HOLDINGS INC.
Close
199.14
-0.610 -0.306%
Share volume: 19,655
Last Updated: Fri 27 Dec 2024 08:30:00 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.90%
PREVIOUS CLOSE
CHG
CHG%
$199.75
-0.61
-0.31%
Fundamental analysis
54%
Profitability
34%
Dept financing
48%
Liquidity
52%
Performance
74%
Performance
5 Days
0.57%
1 Month
-0.59%
3 Months
-14.71%
6 Months
-5.88%
1 Year
-13.66%
2 Year
-1.33%
Key data
Stock price
$199.14
DAY RANGE
$198.62 - $201.04
52 WEEK RANGE
$193.20 - $261.73
52 WEEK CHANGE
-$13.45
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
10/31/2024
Company detail
CEO: Ari Bousbib
Region: US
Website: iqvia.com
Employees: 86,000
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: iqvia.com
Employees: 86,000
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and Asia-Pacific. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services. The Research & Development Solutions segment provides project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services.
Recent news